- All sections
- C - Chemistrymetallurgy
- C08B - Polysaccharidesderivatives thereof
- C08B 37/10 - HeparinDerivatives thereof
Patent holdings for IPC class C08B 37/10
Total number of patents in this class: 151
10-year publication summary
|
4
|
9
|
5
|
5
|
2
|
3
|
2
|
5
|
7
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Agency for Science, Technology and Research | 3639 |
11 |
| Momenta Pharmaceuticals, Inc. | 297 |
9 |
| Laboratorios Farmaceuticos Rovi, S.A. | 239 |
8 |
| Sanofi | 4089 |
8 |
| Rensselaer Polytechnic Institute | 829 |
4 |
| Suzhou Ronnsi Pharma Co., Ltd. | 6 |
4 |
| sanofi-aventis | 363 |
4 |
| Tsinghua University | 5951 |
3 |
| Dilafor AB | 19 |
3 |
| Dilaforette AB | 3 |
3 |
| Shandong University | 1053 |
3 |
| The University of North Carolina at Chapel Hill | 2052 |
3 |
| Shenzhen Hepalink Pharmaceutical Group Co., Ltd. | 14 |
3 |
| Ajinomoto Co., Inc. | 2291 |
2 |
| The Board of Regents of the University of Oklahoma | 618 |
2 |
| Cantex Pharmaceuticals, Inc. | 23 |
2 |
| Cisen Pharmaceutical Co., Ltd. | 25 |
2 |
| Glytech, Inc. | 65 |
2 |
| National University Corporation Chiba University | 502 |
2 |
| Reliable Biopharmaceutical, LLC | 9 |
2 |
| Other owners | 71 |